WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2010148085) RNA NANOPARTICLES AND METHODS OF USE
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2010/148085    International Application No.:    PCT/US2010/038818
Publication Date: 23.12.2010 International Filing Date: 16.06.2010
IPC:
A61K 47/48 (2006.01), C12N 15/11 (2006.01)
Applicants: THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES [US/US]; Office Of Technology Transfer National Institutes Of Health 6011 Executive Boulevard, Suite 325, Msc 7660 Bethesda, MD 20892-7660 (US) (For All Designated States Except US).
REGENTS OF THE UNIVERSITY OF CALIFORNIA [US/US]; 1111 Franklin Street, 12th Floor Oakland, CA 94607 (US) (For All Designated States Except US).
SHAPIRO, Bruce, A. [US/US]; (US) (For US Only).
YINGLING, Yaroslava, G. [RU/US]; (US) (For US Only).
BINDEWALD, Eckart [DE/US]; (US) (For US Only).
KASPRZAK, Wojcieck [US/US]; (US) (For US Only).
JAEGER, Luc [US/US]; (US) (For US Only).
SEVERCAN, Isil [US/US]; (US) (For US Only).
GEARY, Cody [US/US]; (US) (For US Only).
AFONIN, Kirill [RU/US]; (US) (For US Only)
Inventors: SHAPIRO, Bruce, A.; (US).
YINGLING, Yaroslava, G.; (US).
BINDEWALD, Eckart; (US).
KASPRZAK, Wojcieck; (US).
JAEGER, Luc; (US).
SEVERCAN, Isil; (US).
GEARY, Cody; (US).
AFONIN, Kirill; (US)
Agent: CORLESS, Peter, F.; Edwards Angell Palmer & Dodge LLP P.O. Box 55874 Boston, MA 02205 (US)
Priority Data:
61/187,495 16.06.2009 US
Title (EN) RNA NANOPARTICLES AND METHODS OF USE
(FR) NANOPARTICULES D'ARN ET PROCÉDÉS D'UTILISATION
Abstract: front page image
(EN)The instant invention provides polyvalent RNA nanoparticles comprising RNA motifs as building blocks that can form RNA nanotubes. The polyvalent RNA nanoparticles are suitable for therapeutic or diagnostic use in a number of diseases or disorders.
(FR)La présente invention porte sur des nanoparticules d'ARN polyvalentes comprenant des motifs d'ARN en tant que blocs de construction qui peuvent former des nanotubes d'ARN. Les nanoparticules d'ARN polyvalentes sont appropriées pour une utilisation thérapeutique ou de diagnostic dans un nombre de maladies ou de troubles.
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KN, KP, KR, KZ, LA, LC, LK, LR, LS, LT, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PE, PG, PH, PL, PT, RO, RS, RU, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LR, LS, MW, MZ, NA, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, SE, SI, SK, SM, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)